Although some major determinants of myocardial fibrosis are recognised, inhibition of upstream molecules, such as transforming growth factor beta-1 (TGFβ1) has detrimental pleiotropic effects, limiting their viability as therapeutic targets [5, 6]. This evidence concerns the gene TGFB1 and Myocardial fibrosis.